Gland Pharma Limited, a small-molecule generic injectables-focused company, announced it has appointed Yao Fang to the company’s Board of Directors, with effect from March 10, 2022. Also, Srinivas Sadu has been re-appointed as Managing Director and Chief Executive Officer, effective March 10, 2022. According to the company’s exchange filing, “We would like to inform you…